Can I take Bilastine (Blexten) with Montelukast?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Taking Bilastine (Blexten) with Montelukast: Safety and Efficacy

Yes, you can safely take Bilastine (Blexten) together with Montelukast as there are no significant drug interactions between these medications, and this combination may provide complementary benefits for allergic conditions.

Mechanism of Action and Rationale

These medications work through different mechanisms:

  • Bilastine (Blexten): A second-generation antihistamine that blocks H1 receptors, reducing symptoms like sneezing, itching, and rhinorrhea
  • Montelukast: A leukotriene receptor antagonist (LTRA) that blocks leukotrienes, reducing inflammation and helping with nasal congestion

Evidence Supporting Combination Use

The combination of antihistamines with montelukast has been studied and found to be both safe and potentially more effective than either medication alone:

  • A 2023 Phase III randomized clinical trial specifically evaluated the fixed-dose combination of Bilastine 20mg and Montelukast 10mg in patients with allergic rhinitis, finding it to be efficacious and well-tolerated 1

  • The combination of antihistamines and LTRAs may provide additive benefits for allergic rhinitis symptoms, as noted in rhinitis management guidelines 2

  • For patients with both allergic rhinitis and asthma, this combination can be particularly beneficial as montelukast is approved for both conditions 2

Safety Considerations

  • Both medications have favorable safety profiles when used individually:

    • Montelukast has shown a safety profile similar to placebo in controlled clinical trials 3
    • Bilastine is a non-sedating antihistamine with minimal side effects
  • The combination has not shown any significant adverse drug interactions in clinical studies 1

Special Considerations

  1. FDA Boxed Warning for Montelukast: In March 2020, the FDA added a Boxed Warning for montelukast regarding neuropsychiatric events (mood changes, behavior changes, suicidal thoughts) 2. Be aware of these potential side effects.

  2. Asthma Management: If you have asthma along with allergic rhinitis, this combination may be particularly beneficial. Montelukast is approved for both conditions and can help manage combined upper and lower airway symptoms 2, 4.

  3. Alternative Options: If this combination doesn't provide adequate symptom control, intranasal corticosteroids are generally more effective than the combination of antihistamine and LTRA for allergic rhinitis 2.

Dosing Recommendations

  • Bilastine (Blexten): Typically 20mg once daily
  • Montelukast: 10mg once daily (for adults)

Conclusion

The combination of Bilastine (Blexten) and Montelukast is safe and may provide complementary benefits for allergic symptoms. This combination can be particularly useful if you have both allergic rhinitis and asthma, as montelukast addresses both conditions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2001

Guideline

Asthma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.